financetom
ANGO
financetom
/
Healthcare
/
ANGO
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
AngioDynamics, Inc.ANGO
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

AngioDynamics, Inc. provides invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology in the United States and internationally.

It offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium for treatment of peripheral arterial disease.

The company's thrombus management portfolio includes AlphaVac system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac circuit is indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure.

In addition, it offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures.

The company also provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators.

AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.

Latest News >
'GTA VI' delay weighs on global videogame market growth, data shows
'GTA VI' delay weighs on global videogame market growth, data shows
Jun 17, 2025
(Reuters) -The global videogame market's growth rate is expected to improve marginally in 2025 from the previous year, according to a report from research firm Newzoo, seen exclusively by Reuters on Tuesday. Analysts and industry experts had projected a surge in industry growth this year due to the expected blockbuster launch of Take-Two's Grand Theft Auto VI and new consoles....
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Dime Community Bancshares Receives New Jersey Regulator's Approval for New Branch
Dime Community Bancshares Receives New Jersey Regulator's Approval for New Branch
Jun 17, 2025
09:07 AM EDT, 06/17/2025 (MT Newswires) -- Dime Community Bancshares ( DCOM ) said Tuesday that a new branch location in New Jersey has received approval from the state's Department of Banking and Insurance. The Federal Reserve Bank of New York and the New York State Department of Financial Services have previously approved the branch located at 500 Boulevard of...
Agenus Partners With Noetik to Advance Biomarker Discovery for Lead Cancer Immunotherapy Combo
Agenus Partners With Noetik to Advance Biomarker Discovery for Lead Cancer Immunotherapy Combo
Jun 17, 2025
09:06 AM EDT, 06/17/2025 (MT Newswires) -- Agenus ( AGEN ) said Tuesday that it has formed a research collaboration with Noetik to identify predictive biomarkers for its lead immuno-oncology combination, botensilimab and balstilimab. Agenus ( AGEN ) said the collaboration will leverage Noetik's AI-powered OCTO virtual cell models, which are trained on extensive tumor data, to analyze clinical outcomes...
Copyright 2023-2026 - www.financetom.com All Rights Reserved